MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. The company is headquartered in San Diego, California and currently employs 28 full-time employees. The company went IPO on 2003-12-18. The firm's treasury initiative is anchored by Litecoin. The firm has discontinued the clinical development of voruciclib, while certain nonclinical activities related to its drug candidate assets continue to be conducted by it. As part of the review of strategic alternatives, the Company may consider options such as out-licensing opportunities for existing programs and merger and acquisition opportunities.
Based on 6 analysts giving stock ratings to LITS, updated on Sep 01, 2025
Sell
Strong buy
0
Buy
0
Hold
3
Sell
1
Strong sell
2
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for LITS. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: LITS is a Sell candidate.
LITS stock price ended at $1.09 on Tuesday, after dropping 0.91%
On the latest trading day May 19, 2026, the stock price of LITS fell by 0.91%, dropping from $1.08 to $1.09. During the session, the stock saw a volatility of 2.78%, with prices oscillating between a daily low of $1.08 and a high of $1.11. On the latest trading day, the trading volume for LITS decreased by 358.0K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 222.2K shares were traded, with a market value of approximately $39.6M.
LITS Technical Signals
Technical Signals Summary
Buy Signals 4
Neutral Signals 1
Sell Signals 2
Strong Sell
Sell
Neutral
Buy
Strong Buy
LITS currently exhibits 4 buy signals and 2 sell signals. The stock has been in an downtrend since 12:00 AM, with a total price change of -10.66% during this period. Overall, the technical indicators point to a Buy outlook for the mid-term.
Bullish/Bearish Signals for LITS
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for LITS. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to LITS?
According to technical analysis, Lite Strategy Inc has an aggregate signal of Buy. Lite Strategy Inc has 4 Buy signals, 1 Neutral Signals and 2 sell signals.
What are the Fibonacci retracement levels for LITS?
The Fibonacci retracement level for Lite Strategy Inc is between 0% and 23.6%
What is the RSI for Lite Strategy Inc?
The RSI for Lite Strategy Inc is currently 34.56, indicating a neutral condition
What is Lite Strategy Inc price for the next 12 months?
Lite Strategy Inc LITS price for the next 12 months is estimated at $0.
How high is Lite Strategy Inc expected to go?
According to wall street analysts, Lite Strategy Inc is expected to reach a high forecast of $0.